Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Comparing Corporate Presentations

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Jul 31, 2022 12:02pm

146 Views

Post# 34863088

RE:RE:RE:RE:RE:RE:RE:RE:Comparing Corporate Presentations

I have spoken with Bucknelly on the phone on a number of occasions and he is much more balanced than he appears online. Not sure why that is but he appears to to like having a negative online personna. Hopefully, he will up his online game to bring the full arsenal of his thinking, both positive and negative.